Qube Research & Technologies (QRT)
HGEN

Qube Research & Technologies (QRT)’s HUMANIGEN, INC. HGEN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38,691
Closed -$7K – 3156
2022
Q3 		$7K Sell
38,691
-5,079
-12% -$2.73K ﹤0.01% 2387
2022
Q2 		$77K Buy
+43,770
New +$98.3K ﹤0.01% 2028
2022
Q1 		– Sell
-246,403
Closed -$917K – 3191
2021
Q4 		$917K Buy
+246,403
New +$1.44M 0.01% 1246
2021
Q3 		– Sell
-114,064
Closed -$1.98M – 2948
2021
Q2 		$1.98M Buy
114,064
+98,045
+612% +$1.79M 0.02% 702
2021
Q1 		$306K Sell
16,019
-63,184
-80% -$1.15M ﹤0.01% 1453
2020
Q4 		$1.39M Buy
+79,203
New +$948K 0.02% 764

Other funds holding HGEN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HGEN Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of HUMANIGEN, INC. (HGEN) in Q4 2022, closing a stake of 38,691 shares — an estimated $7K sold.

Qube Research & Technologies (QRT) first reported a position in HGEN in Q4 2020 and held it in 6 quarters. The position peaked at $1.98M in Q2 2021. 48 funds tracked by Wall St. Rank hold HGEN as of Q4 2022.

  • Qube Research & Technologies (QRT) reported no remaining HUMANIGEN, INC. position as of Q4 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 38,691 HUMANIGEN, INC. shares in Q4 2022, an estimated $7K.
  • Qube Research & Technologies (QRT) first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s HUMANIGEN, INC. position peaked at $1.98M in Q2 2021.
  • 48 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.